Annual EBIT
$610.64 M
+$66.75 M+12.27%
31 December 2022
Summary:
Horizon Therapeutics Public Limited annual earnings before interest & taxes is currently $610.64 million, with the most recent change of +$66.75 million (+12.27%) on 31 December 2022. During the last 3 years, it has risen by +$149.38 million (+32.39%). HZNP annual EBIT is now at all-time high.HZNP EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
$147.35 M
+$112.61 M+324.13%
30 June 2023
Summary:
Horizon Therapeutics Public Limited quarterly earnings before interest & taxes is currently $147.35 million, with the most recent change of +$112.61 million (+324.13%) on 30 June 2023. HZNP quarterly EBIT is now -55.38% below its all-time high of $330.22 million, reached on 30 September 2021.HZNP Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
$512.54 M
+$61.15 M+13.55%
30 June 2023
Summary:
Horizon Therapeutics Public Limited TTM earnings before interest & taxes is currently $512.54 million, with the most recent change of +$61.15 million (+13.55%) on 30 June 2023. HZNP TTM EBIT is now -42.77% below its all-time high of $895.53 million, reached on 31 March 2022.HZNP TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HZNP EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | +32.4% | -55.4% | -7.1% |
| 5 y5 years | +1483.6% | +1719.6% | +438.1% |
HZNP EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +32.4% | -55.4% | +324.1% | -42.8% | +13.6% |
| 5 y | 5 years | at high | +1483.6% | -55.4% | +193.5% | -42.8% | +771.0% |
| alltime | all time | at high | +283.8% | -55.4% | +172.5% | -42.8% | +216.3% |
Horizon Therapeutics Public Limited EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | $147.35 M(+324.1%) | $512.54 M(+13.5%) |
| Mar 2023 | - | $34.74 M(-79.9%) | $451.39 M(-26.1%) |
| Dec 2022 | $610.64 M(+12.3%) | $172.89 M(+9.7%) | $610.64 M(-9.0%) |
| Sept 2022 | - | $157.56 M(+82.8%) | $670.85 M(-20.5%) |
| June 2022 | - | $86.20 M(-55.6%) | $843.51 M(-5.8%) |
| Mar 2022 | - | $194.00 M(-16.8%) | $895.53 M(+64.7%) |
| Dec 2021 | $543.89 M(+17.9%) | $233.10 M(-29.4%) | $543.89 M(-1.4%) |
| Sept 2021 | - | $330.22 M(+138.9%) | $551.86 M(+26.7%) |
| June 2021 | - | $138.21 M(-187.7%) | $435.58 M(+36.6%) |
| Mar 2021 | - | -$157.64 M(-165.4%) | $318.89 M(-30.9%) |
| Dec 2020 | $461.26 M(+589.8%) | $241.06 M(+12.7%) | $461.26 M(+68.2%) |
| Sept 2020 | - | $213.94 M(+893.9%) | $274.18 M(+301.2%) |
| June 2020 | - | $21.52 M(-240.9%) | $68.33 M(+16.1%) |
| Mar 2020 | - | -$15.27 M(-128.3%) | $58.84 M(-12.0%) |
| Dec 2019 | $66.86 M(+73.4%) | $53.98 M(+566.6%) | $66.86 M(-29.8%) |
| Sept 2019 | - | $8.10 M(-32.7%) | $95.25 M(-36.4%) |
| June 2019 | - | $12.04 M(-266.0%) | $149.70 M(+0.8%) |
| Mar 2019 | - | -$7.25 M(-108.8%) | $148.56 M(+285.3%) |
| Dec 2018 | $38.56 M(-111.6%) | $82.36 M(+31.7%) | $38.56 M(-159.2%) |
| Sept 2018 | - | $62.55 M(+473.9%) | -$65.17 M(-57.3%) |
| June 2018 | - | $10.90 M(-109.3%) | -$152.81 M(-55.5%) |
| Mar 2018 | - | -$117.26 M(+448.7%) | -$343.40 M(+3.3%) |
| Dec 2017 | -$332.29 M(+137.0%) | -$21.37 M(-14.8%) | -$332.29 M(-24.6%) |
| Sept 2017 | - | -$25.08 M(-86.0%) | -$440.64 M(+2.4%) |
| June 2017 | - | -$179.69 M(+69.3%) | -$430.10 M(+96.4%) |
| Mar 2017 | - | -$106.14 M(-18.2%) | -$218.95 M(+56.2%) |
| Dec 2016 | -$140.20 M | -$129.72 M(+791.5%) | -$140.20 M(+7569.8%) |
| Sept 2016 | - | -$14.55 M(-146.3%) | -$1.83 M(-103.1%) |
| June 2016 | - | $31.46 M(-214.8%) | $58.28 M(-170.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2016 | - | -$27.39 M(-416.4%) | -$82.59 M(+31.5%) |
| Dec 2015 | -$62.81 M(-74.5%) | $8.66 M(-81.0%) | -$62.81 M(-34.4%) |
| Sept 2015 | - | $45.56 M(-141.6%) | -$95.72 M(-30.2%) |
| June 2015 | - | -$109.42 M(+1338.2%) | -$137.06 M(+172.4%) |
| Mar 2015 | - | -$7.61 M(-68.6%) | -$50.32 M(-79.5%) |
| Dec 2014 | -$245.86 M(+79.0%) | -$24.25 M(-675.2%) | -$245.86 M(-23.8%) |
| Sept 2014 | - | $4.21 M(-118.6%) | -$322.54 M(-1.8%) |
| June 2014 | - | -$22.68 M(-88.8%) | -$328.38 M(+2.3%) |
| Mar 2014 | - | -$203.15 M(+101.3%) | -$321.05 M(+133.7%) |
| Dec 2013 | -$137.35 M(+68.7%) | -$100.93 M(+6107.1%) | -$137.35 M(+126.6%) |
| Sept 2013 | - | -$1.63 M(-89.4%) | -$60.62 M(-21.4%) |
| June 2013 | - | -$15.35 M(-21.1%) | -$77.12 M(-5.4%) |
| Mar 2013 | - | -$19.45 M(-19.6%) | -$81.52 M(+0.1%) |
| Dec 2012 | -$81.41 M(-33.1%) | -$24.20 M(+33.5%) | -$81.41 M(-44.8%) |
| Sept 2012 | - | -$18.13 M(-8.2%) | -$147.49 M(+1.7%) |
| June 2012 | - | -$19.75 M(+2.1%) | -$145.02 M(+8.2%) |
| Mar 2012 | - | -$19.34 M(-78.6%) | -$134.01 M(+10.5%) |
| Dec 2011 | -$121.66 M(+392.5%) | -$90.27 M(+476.6%) | -$121.24 M(+395.1%) |
| Sept 2011 | - | -$15.65 M(+79.0%) | -$24.49 M(+19.8%) |
| June 2011 | - | -$8.75 M(+33.2%) | -$20.44 M(+378.6%) |
| Mar 2011 | - | -$6.57 M(-201.3%) | -$4.27 M(-19.8%) |
| Dec 2010 | -$24.70 M(+31.5%) | $6.48 M(-155.9%) | -$5.32 M(-69.5%) |
| Sept 2010 | - | -$11.60 M(-256.4%) | -$17.48 M(+70.3%) |
| June 2010 | - | $7.42 M(-197.4%) | -$10.26 M(-53.8%) |
| Mar 2010 | - | -$7.62 M(+34.3%) | -$22.23 M(+18.3%) |
| Dec 2009 | -$18.79 M(-30.1%) | -$5.67 M(+29.4%) | -$18.79 M(+43.3%) |
| Sept 2009 | - | -$4.39 M(-3.5%) | -$13.11 M(+50.3%) |
| June 2009 | - | -$4.54 M(+8.6%) | -$8.73 M(+108.6%) |
| Mar 2009 | - | -$4.18 M | -$4.18 M |
| Dec 2008 | -$26.87 M | - | - |
FAQ
- What is Horizon Therapeutics Public Limited annual earnings before interest & taxes?
- What is the all time high annual EBIT for Horizon Therapeutics Public Limited?
- What is Horizon Therapeutics Public Limited quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Horizon Therapeutics Public Limited?
- What is Horizon Therapeutics Public Limited TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Horizon Therapeutics Public Limited?
What is Horizon Therapeutics Public Limited annual earnings before interest & taxes?
The current annual EBIT of HZNP is $610.64 M
What is the all time high annual EBIT for Horizon Therapeutics Public Limited?
Horizon Therapeutics Public Limited all-time high annual earnings before interest & taxes is $1.00 B
What is Horizon Therapeutics Public Limited quarterly earnings before interest & taxes?
The current quarterly EBIT of HZNP is $147.35 M
What is the all time high quarterly EBIT for Horizon Therapeutics Public Limited?
Horizon Therapeutics Public Limited all-time high quarterly earnings before interest & taxes is $330.22 M
What is Horizon Therapeutics Public Limited TTM earnings before interest & taxes?
The current TTM EBIT of HZNP is $512.54 M
What is the all time high TTM EBIT for Horizon Therapeutics Public Limited?
Horizon Therapeutics Public Limited all-time high TTM earnings before interest & taxes is $895.53 M